Source: The Journal of Infectious Diseses. Unidade: FM
Subjects: FIBROSE CÍSTICA (ESTUDO CLÍNICO), REAÇÃO EM CADEIA POR POLIMERASE, DOENÇAS RESPIRATÓRIAS, CORONAVIRUS (PATOLOGIA;PATOGENICIDADE), CRIANÇAS, CORONAVIRUS (IMPACTO;ESTUDO CLÍNICO)
ABNT
SILVA FILHO, Luiz Vicente Ribeiro Ferreira da et al. The differential clinical impact of human coronavirus species in children with cystic fibrosis. The Journal of Infectious Diseses, v. 206, n. 3, p. 384-388, 2012Tradução . . Disponível em: https://doi.org/10.1093/infdis/jis274. Acesso em: 02 nov. 2024.APA
Silva Filho, L. V. R. F. da, Zerbinati, R. M., Tateno, A. F., Boas, L. V., Almeida, M. B. de, Levi, J. E., et al. (2012). The differential clinical impact of human coronavirus species in children with cystic fibrosis. The Journal of Infectious Diseses, 206( 3), 384-388. doi:10.1093/infdis/jis274NLM
Silva Filho LVRF da, Zerbinati RM, Tateno AF, Boas LV, Almeida MB de, Levi JE, Drexler JF, Drosten C, Pannuti CS. The differential clinical impact of human coronavirus species in children with cystic fibrosis [Internet]. The Journal of Infectious Diseses. 2012 ; 206( 3): 384-388.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1093/infdis/jis274Vancouver
Silva Filho LVRF da, Zerbinati RM, Tateno AF, Boas LV, Almeida MB de, Levi JE, Drexler JF, Drosten C, Pannuti CS. The differential clinical impact of human coronavirus species in children with cystic fibrosis [Internet]. The Journal of Infectious Diseses. 2012 ; 206( 3): 384-388.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1093/infdis/jis274